Great progress has been made in the field of hereditary metabolic diseases
since the beginning of the past century, when metabolic disorders were not
really understood and could only be clinically described. Due to the develo
pment of basic sciences and advances in technology, we gained insight in th
e biochemical and molecular basis of hereditary metabolic diseases. It open
ed possibilities for their treatment, and also led to the discovery of more
metabolic diseases, so today, there are more than 500 "inborn errors of me
tabolism" known. Although each of these diseases is quite rare, as a group,
however, they affect about 1-2% of newborns and therefore pose a significa
nt health problem. The realization about 50 years ago that some hereditary
diseases are curable if timely diagnosed led to the introduction of newborn
screening in most countries. Modern technologies in this field allow early
diagnosis of more than 30 inborn errors of metabolism. Nevertheless, to di
agnose most patients correctly, both selective screening involving teamwork
and proper use of current technology are required. In addition to consider
able development of diagnostic possibilities, the past decade was marked by
advances in the therapy of inborn errors of metabolism. A number of clinic
al trials are currently underway, promising new and more effective approach
es in the treatment of these patients. Thus, the field of inborn errors of
metabolism at the beginning of the new millennium continues to be a scienti
fic challenge to modern medicine.